Free Trial
→ Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (From Colonial Metals) (Ad)

10 Best Small Cap Stocks to Buy Now - 1 of 10

Slide 1
Introduction
Continue to 2
 
Introduction
Continue to 2
 

Quince Therapeutics (NASDAQ:QNCX)

Consensus Rating
Strong Buy
Rating Score
3.5
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$8.50 (451.9% Upside)

About Quince Therapeutics

Quince Therapeutics logoQuince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/7/2024Maxim GroupInitiated CoverageBuy$6.00
10/29/2024RODMAN&RENSHAWUpgradeStrong-Buy
10/29/2024Rodman & RenshawInitiated CoverageBuy$11.00
10/22/2024EF Hutton Acquisition Co. IUpgradeStrong-Buy
Slide 1
Introduction
Continue to 2
 

“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

More From MarketBeat
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
20 Stocks Wall Street Analysts Love the Most
Every trading day, between 500 and 800 new recommendations and research reports are issued by sell-side equiti...
MarketBeat
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
7 Artificial Intelligence Stocks That Are Still Long-Term Winners
It's hard to believe that two years ago, many of us had never heard of ChatGPT. But for the last 18 months, in...
MarketBeat
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...
Crypto Swap Profits | Sponsored
10 Rock-Solid Dividend Paying Stocks to Add to Your Portfolio
While interest rates have risen over the last few years, there's still two things that fixed-income investment...
MarketBeat